secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001551306-24-000152
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny Q2 beats on adjusted EBITDA but cuts full-year guidance on lower revenue per member
--------------------------------------------------------------------------------

- Q2 revenue $304.1M (+8.8% YoY), record Adj. EBITDA $54.5M (+15% YoY), margin 17.9%.
- Net income $16.5M ($0.17 diluted EPS); Adj. EPS $0.43 vs $0.36 a year ago.
- Board authorized $100M stock buyback; 6.8M shares repurchased YTD under prior programs.
- Full-year 2024 revenue guidance revised to $1.165-1.20B (7-10% growth); Adj. EBITDA $199-209M.
- Q3 2024 revenue guidance $290-303M; Adj. EBITDA $47.5-51.0M; citing lower revenue per utilizing member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130624000152/0001551306-24-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130624000152/pgny-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001551306-24-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer